Powered by Connections Older Adults Resource Fair

Inova celebrates Older Americans Month Fairfax, VA, May 13, 2024 — Inova is dedicated to supporting programs and opportunities that make a difference in the quality of life, health and welfare of our community’s older adults. As part of Inova’s recognition of Older Adults Month, a free resource fair is being held at the Inova…

Read More

Inova partners with transplant patients to improve patient care experience

In 2020, the transplant team at Inova established a Patient and Family Advisory Council (PFAC) to enhance healthcare delivery for transplant patients and improve their overall experience. The PFAC serves as a platform for patients and caregivers to share valuable feedback and insights with the transplant team on better meeting patient needs during the various…

Read More

Inova introduces a groundbreaking procedure to control resistant high blood pressure

According to the U.S. Centers for Disease Control and Prevention, nearly 50% of adults in America suffer from high blood pressure. Uncontrolled, this condition can lead to severe health complications such as heart disease, stroke, heart failure, kidney disease and dementia. On April 25, Inova Schar Heart and Vascular unveiled a revolutionary, minimally invasive procedure…

Read More

Giving the gift of life: Demystifying the process of becoming a living kidney donor

Heather Perez Saiz, MA, LCSW, CCTSW, is the Independent Living Donor Advocate at Inova Fairfax Medical Campus. Kirsten Curtis is the Transplant Coordinator at Inova Fairfax Medical Campus. Currently there are almost 90,000 people on the kidney transplant list in the United States and the need is greater than ever. In 2023, there were approximately…

Read More

Inova Schar Heart and Vascular receives $1.4 million pediatric heart transplant research grant

Fairfax, VA — A research team at Inova Schar Heart and Vascular recently received nearly $1.4 million to develop a new blood test that doctors can use to optimize the immunosuppression medications needed after pediatric heart transplant. The team will be led by Palak Shah, MD, MS, Director of the Inova Cardiovascular Genomics Center and…

Read More

Inova plays a key role in trial of innovative treatment for tricuspid valve regurgitation that is now approved by the FDA

Update as of April 24, 2024: Inova’s structural heart team has now completed the first case in the Washington, DC region since the FDA approved a new device to treat tricuspid regurgitation (TR). Inova Schar Heart and Vascular’s Structural Heart/Valve Disease Program was among the top enrollers in the TRILUMINATE™ Pivotal Trial demonstrating the safety…

Read More